Alexandria Real Estate Equities Inc. ($ARE) Stock Forecast: Down 5.7% Today

What is Alexandria Real Estate Equities Inc.?

Alexandria Real Estate Equities, Inc. (ARE) is a notable real estate investment trust (REIT) specializing in life science and technology campuses. The company is dedicated to offering innovative spaces for leading life science and technology entities to thrive.

Why is Alexandria Real Estate Equities Inc. going down?

ARE stock is down 5.7% on Feb 12, 2026 15:22

• The decline in ARE's stock today could be linked to challenges stemming from oversupply and weak demand in the life sciences real estate market.
• The suggestion to consider adding ARE shares at a price below $50 for patient investors reflects a cautious stance on the stock's short-term performance.
• Despite notable increases in stake by Oppenheimer Asset Management Inc., industry challenges and limited growth prospects in the coming years may have influenced the stock price negatively.
• Market response could be influenced by the broader sentiment towards the real estate sector, particularly with contrasting performances of companies like Ventas (VTR) observing significant revenue and net profit growth.

ARE Price Chart

ARE Technical Analysis

ARE News

Biogen Announces Board Chair Transition

Biogen Inc. announced that Dr. Maria C. Freire has been elected as the new Chair of its Board of Directors, effective after the 2026 Annual Meeting of Stockholders on June 9, 2026. Dr. Freire will succeed Caroline Dorsa, who is retiring from the board. Dr. Freire, who joined the board in 2021, brings extensive experience in biomedical innovation and drug development to her new role.

https://investors.biogen.com/news-releases/news-release-details/biogen-announces-board-chair-transition

RBC Capital Keeps Their Buy Rating on Ventas (VTR)

RBC Capital has maintained its Buy rating on Ventas (VTR) with a price target of $91.00, following the company's shares closing at $82.75. Analyst Michael Carroll, a 5-star analyst, covers the Real Estate sector and has an average return of 7.5%. This follows Ventas's Q3 earnings report showing a significant increase in revenue and net profit compared to the previous year.

https://www.theglobeandmail.com/investing/markets/stocks/VTR-N/pressreleases/151887/rbc-capital-keeps-their-buy-rating-on-ventas-vtr/

Alexandria Real Estate: Dealing With Oversupply And Weak Demand (Rating Downgrade)

Alexandria Real Estate (ARE) faces challenges due to oversupply and weak demand in the life sciences real estate market, leading to a dividend cut and a "Hold" rating. Despite strong financials and management, growth prospects are muted for the next 3-5 years, influenced by industry headwinds and a shift in capital towards AI. The author recommends adding ARE shares only below $50 for patient investors, anticipating a long recovery period before robust growth resumes.

https://seekingalpha.com/article/4868596-alexandria-real-estate-dealing-with-oversupply-and-weak-demand-rating-downgrade

Oppenheimer Asset Management Inc. Buys 38,071 Shares of Alexandria Real Estate Equities, Inc. $ARE

Oppenheimer Asset Management Inc. significantly increased its stake in Alexandria Real Estate Equities, Inc. (ARE) by 186.8% in the third quarter of 2025, now holding 58,449 shares worth approximately $4.87 million. This move is part of broader institutional interest, with hedge funds and other institutional investors owning 96.54% of the company's stock. The article also highlights Alexandria's active liability management, including a $750 million senior note offering and a $500 million share repurchase authorization, alongside recent financial performance and analyst ratings.

https://www.marketbeat.com/instant-alerts/filing-oppenheimer-asset-management-inc-buys-38071-shares-of-alexandria-real-estate-equities-inc-are-2026-02-11/

What Is AMREP Corporation's (NYSE:AXR) Share Price Doing?

AMREP Corporation (NYSE:AXR) recently saw a double-digit share price rise, although it remains below its yearly peak, presenting a potential mispricing opportunity for this less-covered small-cap. The company's stock is currently trading at a relatively cheap price compared to the Real Estate industry average, with a P/E ratio of 11.3x versus the peer average of 29.13x. Despite a projected unexciting earnings growth of 9.2%, its current valuation below the industry P/E ratio might make it an opportune time for both current shareholders to accumulate more and potential investors to enter the stock.

https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-axr/amrep/news/what-is-amrep-corporations-nyseaxr-share-price-doing/amp

Trending Today

Enphase Energy Inc. ($ENPH) Stock Forecast: Down 8.7% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.0% Today

KeyCorp ($KEY) Stock Forecast: Down 5.1% Today

Expedia Group Inc. ($EXPE) Stock Forecast: Down 5.3% Today

Hewlett Packard Enterprise Company ($HPE) Stock Forecast: Down 6.7% Today

Bruker Corporation ($BRKR) Stock Forecast: Down 13.1% Today

Alaska Air Group Inc. ($ALK) Stock Forecast: Down 5.7% Today

V.F. Corporation ($VFC) Stock Forecast: Down 5.0% Today

DaVita Inc. ($DVA) Stock Forecast: Up 5.5% Today

United Continental Holdings Inc. ($UAL) Stock Forecast: Down 5.4% Today

Alexandria Real Estate Equities Inc. Price History

07.00.2026 - ARE Stock was up 7.1%

• Despite challenges like securities class action lawsuits, a real estate impairment charge, and unmet financial expectations in Q3 2025, ARE's stock displayed a bullish movement.
• The unveiling of a significant biosciences campus plan in Redwood City likely had a positive impact on investor sentiment towards ARE, hinting at growth prospects in the life sciences field.
• Market sentiment varies, evident in diverse analyst price targets and ongoing legal scrutiny, reflecting investor deliberation on balancing the company's current undervaluation against future uncertainties.
• The stock's recent increase may be attributed to investors factoring in the reminder of the securities class action lawsuit and the repercussions of disappointing financial results, which might already be factored into the stock price.

03.11.2025 - ARE Stock was down 8.2%

• ARE stock experienced a strong bearish movement due to a combination of factors:
• Significant decrease in its quarterly cash dividend for the fourth quarter of 2025 to strengthen its balance sheet and financial flexibility, possibly disappointing income-seeking investors.
• Securities fraud class action lawsuit alleging failure to disclose material information and misrepresentation of leasing volume and development pipeline likely contributing to negative sentiment.
• Market trends were mixed, with companies like American Eagle Outfitters and Microchip Technology experiencing stock rises due to better-than-expected earnings, whereas others like Netflix and ARE faced declines due to weak guidance and legal issues.

03.11.2025 - ARE Stock was down 5.2%

• A 45% decrease in the quarterly cash dividend for the fourth quarter of 2025 has raised concerns among investors about the company's financial stability or the necessity to strengthen its balance sheet.
• Securities fraud class action lawsuits that accuse the company of misrepresenting leasing volume and development pipeline, along with a real estate impairment charge, have led to a loss of investor trust and a pessimistic outlook on ARE stock.
• Allegations of deceptive statements concerning property values and occupancy rates have undermined investor confidence in the company's transparency and governance standards, contributing to the downward trend in the market.
• The convergence of a dividend reduction, financial difficulties, and legal disputes has prompted widespread selling of ARE shares, resulting in the significant bearish movement witnessed recently.

29.00.2026 - ARE Stock was down 5.4%

• ARE reported a substantial net loss, impairment charge, and dividend cut, leading to a 6.6% decline in its stock price. These financial struggles, along with ongoing lawsuits and occupancy pressures, have raised concerns among investors.
• A major investment firm increased its stake in ARE by 22%, indicating confidence in the long-term prospects of the company despite its current difficulties.
• Analysts have given ARE an average "Hold" recommendation, with varying fair-value estimates, reflecting uncertainty about its future performance. The planned asset sales and debt tender offers are seen as necessary for reshaping the company's balance sheet but may lead to short-term occupancy dips and potential dividend cuts.
• The bearish movement of ARE contrasts with the positive performance of a biopharmaceutical firm, which has seen a significant rise in stock price due to promising drug trial results. This juxtaposition highlights the diverging fortunes within the healthcare and real estate sectors.

28.00.2026 - ARE Stock was down 5.1%

• The bearish movement in ARE's stock today can be attributed to the significant net loss reported in Q4 2025, primarily due to real estate impairment charges, which impacted investor confidence in the company's financial health.
• Despite exceeding AFFO and revenue estimates, the market may have reacted negatively to the decline in rental income and operating occupancy, raising concerns about the company's ability to maintain profitability in the near term.
• The ongoing high vacancy rate in the life sciences building in University City, Philadelphia, despite securing a substantial loan, may have also contributed to the bearish sentiment surrounding ARE, reflecting broader uncertainties in the real estate sector.
• Overall, the contrasting narratives of strong FFO resilience but significant net losses have likely led to mixed interpretations of ARE's future profitability, prompting the bearish market movement today.

28.00.2026 - ARE Stock was down 5.0%

• Alexandria Real Estate Equities (ARE) reported a significant net loss for Q4 2025, mainly due to real estate impairment charges, leading to bearish sentiments among investors.
• Despite exceeding AFFO and revenue estimates, the company faced challenges such as a decline in occupancy and negative rental rates, contributing to the bearish market movement.
• Analysts' concerns about weak interest coverage and dividend instability may have further fueled the bearish narrative surrounding ARE's financial health and future profitability.
• The ongoing development in Philadelphia's life sciences sector, as seen with Brandywine securing a loan for a mostly vacant building, highlights potential competition and market dynamics affecting ARE's performance.

27.00.2026 - ARE Stock was down 2.6%

• Concerns over a potential dividend cut and a slowdown in biopharma research spending negatively impacted leasing demand, leading to the bearish movement in ARE stock.
• The exit of ClearBridge Investments from its position in ARE due to ongoing uncertainty and the dividend cut added to the negative sentiment surrounding the stock.
• Despite reporting strong Q4 financial results with FFO per share exceeding estimates, the market reaction was muted, indicating investor caution towards the challenging revenue environment projected for 2026.
• The combination of missed earnings expectations, concerns over future revenue growth, and overall market sentiment contributed to the bearish movement in Alexandria Real Estate Equities (ARE) stock today.

11.01.2026 - ARE Stock was down 5.0%

• The bearish movement in ARE's stock today can be attributed to the challenges the company is facing due to oversupply and weak demand in the life sciences real estate market.
• Despite strong financials and management, the muted growth prospects for the next few years, influenced by industry headwinds and a shift in capital towards AI, have likely contributed to investor concerns and the negative market movement.
• The pricing of a $750 million senior notes offering by Alexandria Real Estate might have also impacted the stock negatively, as investors may be wary of increased debt levels and interest expenses affecting future profitability.
• The significant increase in institutional stake by Oppenheimer Asset Management Inc. could indicate a long-term bullish outlook on the company, but the short-term market sentiment seems to have been influenced more by the challenges and uncertainties.

12.01.2026 - ARE Stock was down 5.7%

• The decline in ARE's stock today could be linked to challenges stemming from oversupply and weak demand in the life sciences real estate market.
• The suggestion to consider adding ARE shares at a price below $50 for patient investors reflects a cautious stance on the stock's short-term performance.
• Despite notable increases in stake by Oppenheimer Asset Management Inc., industry challenges and limited growth prospects in the coming years may have influenced the stock price negatively.
• Market response could be influenced by the broader sentiment towards the real estate sector, particularly with contrasting performances of companies like Ventas (VTR) observing significant revenue and net profit growth.

04.11.2025 - ARE Stock was down 7.1%

• ARE stock saw a substantial decrease of 10.05% in its value today.
• The decline in ARE's stock price is linked to alleged misleading statements concerning its Long Island City property, unsatisfactory Q3 financial results, failure to meet analyst projections, decreases in revenue, adjusted funds from operation, and occupancy rates.
• Legal actions initiated by Faruqi & Faruqi, LLP and Pomerantz LLP through a class action lawsuit heightened investor apprehensions and potentially added to the selling pressure on ARE shares.
• Despite a positive performance in the broader stock market on the same day, ARE lagged behind its competitors and major indices, suggesting internal company challenges that led to negative market sentiment.

04.11.2025 - ARE Stock was down 10.3%

• ARE stock underperformed, falling by 10.05%, hitting a 52-week low at $48.42, and trading 55.26% below its yearly high.
• The class action lawsuit against ARE for alleged securities fraud and below-expectation financial results in Q3 2025 likely contributed to the stock's decline.
• Weak guidance, dividend cuts, and declining bids for Warner Bros. Discovery among other factors led to the negative market sentiment towards ARE.
• Despite maintaining a strong dividend yield and analyst Outperform ratings, the company's recent financial performance and legal challenges have impacted investor confidence, resulting in the bearish movement.

06.00.2026 - ARE Stock was up 2.6%

• Today, ARE experienced a strong bullish movement in the market, despite facing legal challenges and allegations of securities fraud. The market movement can be attributed to several factors:
• The positive market sentiment towards real estate investment trusts (REITs) in the current economic landscape.
• Potential investor optimism regarding ARE's ability to navigate through the legal issues and maintain its position in the market.
• The company's strategic initiatives and strong fundamentals overshadowing the short-term legal uncertainties.
• The overall bullish trend in the real estate sector contributing to the positive movement in ARE's stock price.